Maverick Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,080
Closed -$947K 409
2023
Q3
$947K Sell
6,080
-17,240
-74% -$2.84M 0.02% 128
2023
Q2
$3.86M Buy
23,320
+17,462
+298% +$2.82M 0.08% 67
2023
Q1
$908K Sell
5,858
-6,398
-52% -$1.03M 0.02% 157
2022
Q4
$2.17M Buy
12,256
+4,299
+54% +$742K 0.05% 92
2022
Q3
$1.3M Buy
7,957
+1,882
+31% +$318K 0.03% 121
2022
Q2
$1.08M Buy
6,075
+96
+2% +$17.1K 0.03% 138
2022
Q1
$1.06M Buy
+5,979
New +$1.02M 0.02% 139
2021
Q4
Sell
-37,191
Closed -$6.01M 485
2021
Q3
$6.01M Sell
37,191
-9,596
-21% -$1.64M 0.06% 91
2021
Q2
$7.71M Buy
+46,787
New +$7.75M 0.07% 84
2020
Q2
Sell
-44,249
Closed -$5.8M 622
2020
Q1
$5.8M Sell
44,249
-32,451
-42% -$4.6M 0.12% 73
2019
Q4
$11.2M Sell
76,700
-10,903
-12% -$1.48M 0.16% 57
2019
Q3
$11.3M Buy
87,603
+18,363
+27% +$2.42M 0.17% 58
2019
Q2
$9.64M Buy
69,240
+9,220
+15% +$1.28M 0.14% 68
2019
Q1
$8.39M Buy
60,020
+44,840
+295% +$6.01M 0.11% 100
2018
Q4
$1.96M Sell
15,180
-38,770
-72% -$5.41M 0.03% 240
2018
Q3
$7.45M Sell
53,950
-19,870
-27% -$2.64M 0.09% 107
2018
Q2
$8.96M Sell
73,820
-25,000
-25% -$3.12M 0.1% 94
2018
Q1
$12.7M Buy
98,820
+31,300
+46% +$4.23M 0.16% 69
2017
Q4
$9.43M Buy
67,520
+27,620
+69% +$3.85M 0.12% 59
2017
Q3
$5.19M Buy
39,900
+9,800
+33% +$1.3M 0.07% 62
2017
Q2
$3.98M Buy
30,100
+6,980
+30% +$890K 0.05% 65
2017
Q1
$2.88M Sell
23,120
-5,410
-19% -$646K 0.04% 58
2016
Q4
$3.29M Buy
28,530
+2,210
+8% +$255K 0.04% 49
2016
Q3
$3.11M Sell
26,320
-1,910
-7% -$232K 0.04% 68
2016
Q2
$3.42M Buy
+28,230
New +$3.21M 0.05% 34

Other funds holding JNJ

Maverick Capital's JNJ Position: Q4 2023 in Review

Maverick Capital sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 6,080 shares — an estimated $947K sold.

Maverick Capital first reported a position in JNJ in Q2 2016 and held it in 25 quarters. The position peaked at $12.7M in Q1 2018. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Maverick Capital reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • Maverick Capital sold 6,080 Johnson & Johnson shares in Q4 2023, an estimated $947K.
  • Maverick Capital first reported a position in Johnson & Johnson in Q2 2016 and held it in 25 quarters.
  • Maverick Capital's Johnson & Johnson position peaked at $12.7M in Q1 2018.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Maverick Capital's 13F filing for Q4 2023, filed 14 Feb 2024.